R9I

methyl N-[(4S)-6-chloro-4-[(isoquinolin-4-yl)carbamoyl]-3,4-dihydroisoquinoline-2(1H)-sulfonyl]-N-methylglycinate

Created:	2023-08-22
Last modified:	2023-11-08

Find Related PDB Entry
1 entries where R9I is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	57
Chiral Atom Count	1
Bond Count	60
Aromatic Bond Count	17

2D diagram of R9I

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	methyl N-[(4S)-6-chloro-4-[(isoquinolin-4-yl)carbamoyl]-3,4-dihydroisoquinoline-2(1H)-sulfonyl]-N-methylglycinate
Systematic Name (OpenEye OEToolkits)	methyl 2-[[(4~{S})-6-chloranyl-4-(isoquinolin-4-ylcarbamoyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]sulfonyl-methyl-amino]ethanoate
Formula	C₂₃ H₂₃ Cl N₄ O₅ S
Molecular Weight	502.971
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(OC)CN(C)S(=O)(=O)N1Cc2ccc(Cl)cc2C(C1)C(=O)Nc1cncc2ccccc21
SMILES	CACTVS	3.385	COC(=O)CN(C)[S](=O)(=O)N1C[CH](C(=O)Nc2cncc3ccccc23)c4cc(Cl)ccc4C1
SMILES	OpenEye OEToolkits	2.0.7	CN(CC(=O)OC)S(=O)(=O)N1Cc2ccc(cc2C(C1)C(=O)Nc3cncc4c3cccc4)Cl
Canonical SMILES	CACTVS	3.385	COC(=O)CN(C)[S](=O)(=O)N1C[C@@H](C(=O)Nc2cncc3ccccc23)c4cc(Cl)ccc4C1
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN(CC(=O)OC)S(=O)(=O)N1Cc2ccc(cc2[C@@H](C1)C(=O)Nc3cncc4c3cccc4)Cl
InChI	InChI	1.06	InChI=1S/C23H23ClN4O5S/c1-27(14-22(29)33-2)34(31,32)28-12-16-7-8-17(24)9-19(16)20(13-28)23(30)26-21-11-25-10-15-5-3-4-6-18(15)21/h3-11,20H,12-14H2,1-2H3,(H,26,30)/t20-/m1/s1
InChIKey	InChI	1.06	GLLFHKJANJSNEG-HXUWFJFHSA-N

Related Resource References

Resource Name	Reference
PubChem	169408328

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.